CRESCENT BIOPHARMA, INC. (CBIO) Capital expenditures 2016–2025
CRESCENT BIOPHARMA, INC. (CBIO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$919,000FY2025 · since FY2016: $704,202 → $919,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $919,000 | +9115.8% |
| FY2024 | $9,972 | -53.4% |
| FY2023 | $21,394 | -74.6% |
| FY2022 | $84,191 | +463.4% |
| FY2021 | $14,943 | -78.2% |
| FY2020 | $68,507 | -52.7% |
| FY2019 | $144,928 | +15.4% |
| FY2018 | $125,618 | -57.3% |
| FY2017 | $294,107 | -58.2% |
| FY2016 | $704,202 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice